Our study’s results suggest that cytokine level changes may be linked to treatment response in patients with HNSCC; they show that, after treatment, patients with CR + PR had significantly decreased IL-1β, IL-6, and TNF-α levels and increased IL-2 and leptin levels. This evidence concerns the gene IL1B and head and neck squamous cell carcinoma.